Found: 252
Select item for more details and to access through your institution.
Ghidul ESC de diagnostic şi tratament al insuficienţei cardiace acute şi cronice 2012.
- Published in:
- Romanian Journal of Cardiology, 2013, v. 23, n. 3, p. 245
- By:
- Publication type:
- Article
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1199, doi. 10.1111/dom.13642
- By:
- Publication type:
- Article
Predictive Value of Endostatin in Chronic Heart Failure Patients with Poor Kidney Function.
- Published in:
- Cardiology, 2015, v. 130, n. 1, p. 17, doi. 10.1159/000368220
- By:
- Publication type:
- Article
Neurohormonal Activation in Acute Heart Failure: Results from VERITAS.
- Published in:
- Cardiology, 2011, v. 119, n. 2, p. 96, doi. 10.1159/000330409
- By:
- Publication type:
- Article
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 1, p. 59, doi. 10.7326/M22-2115
- By:
- Publication type:
- Article
Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction.
- Published in:
- European Heart Journal, 2012, v. 33, n. 3, p. 314, doi. 10.1093/eurheartj/ehr433
- By:
- Publication type:
- Article
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction.
- Published in:
- European Heart Journal, 2011, v. 32, n. 10, p. 1227
- By:
- Publication type:
- Article
‘Iron deficiency: an ominous sign in patients with systolic chronic heart failure’ [Eur Heart J 2010;31:1872–1880, doi:10.1093/eurheartj/ehq158].
- Published in:
- European Heart Journal, 2011, v. 32, n. 9, p. 1054, doi. 10.1093/eurheartj/ehr115
- By:
- Publication type:
- Article
Iron deficiency: an ominous sign in patients with systolic chronic heart failure.
- Published in:
- European Heart Journal, 2010, v. 31, n. 15, p. 1872, doi. 10.1093/eurheartj/ehq158
- By:
- Publication type:
- Article
Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in ...
- Published in:
- European Heart Journal, 2010, v. 31, n. 5, p. 624, doi. 10.1093/eurheartj/ehq027
- By:
- Publication type:
- Article
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.
- Published in:
- European Heart Journal, 2010, v. 31, n. 7, p. 824, doi. 10.1093/eurheartj/ehp604
- By:
- Publication type:
- Article
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial.
- Published in:
- European Heart Journal, 2010, v. 31, n. 2, p. 211, doi. 10.1093/eurheartj/ehp425
- By:
- Publication type:
- Article
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.
- Published in:
- European Heart Journal, 2009, v. 30, n. 18, p. 2226, doi. 10.1093/eurheartj/ehp256
- By:
- Publication type:
- Article
Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.
- Published in:
- European Heart Journal, 2007, v. 28, n. 7, p. 829, doi. 10.1093/eurheartj/ehm033
- By:
- Publication type:
- Article
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT trial.
- Published in:
- European Heart Journal, 2007, v. 28, n. 6, p. 685, doi. 10.1093/eurheartj/ehl197
- By:
- Publication type:
- Article
Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
- Published in:
- European Heart Journal, 2007, v. 28, n. 3, p. 326, doi. 10.1093/eurheartj/ehl464
- By:
- Publication type:
- Article
QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence?
- Published in:
- European Heart Journal, 2006, v. 27, n. 24, p. 3074, doi. 10.1093/eurheartj/ehl386
- By:
- Publication type:
- Article
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
- Published in:
- European Heart Journal, 2006, v. 27, n. 12, p. 1447
- By:
- Publication type:
- Article
Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?
- Published in:
- European Heart Journal, 2006, v. 27, n. 11, p. 1270, doi. 10.1093/eurheartj/ehi826
- By:
- Publication type:
- Article
Beta-blockers and heart failure in older people: reply.
- Published in:
- European Heart Journal, 2006, v. 27, n. 7, p. 888, doi. 10.1093/eurheartj/ehi786
- By:
- Publication type:
- Article
Predictors of mortality and morbidity in patients with chronic heart failure.
- Published in:
- European Heart Journal, 2006, v. 27, n. 1, p. 65, doi. 10.1093/eurheartj/ehi555
- By:
- Publication type:
- Article
Public awareness of heart failure in Europe: first results from SHAPE.
- Published in:
- European Heart Journal, 2005, v. 26, n. 22, p. 2413, doi. 10.1093/eurheartj/ehi447
- By:
- Publication type:
- Article
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
- Published in:
- European Heart Journal, 2004, v. 25, n. 21, p. 1911, doi. 10.1016/j.ehj.2004.08.006
- By:
- Publication type:
- Article
Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?
- Published in:
- European Heart Journal, 2004, v. 25, n. 5, p. 357, doi. 10.1016/j.ehj.2003.12.023
- By:
- Publication type:
- Article
Endothelin receptor antagonism in patients with chronic heart failure☆.
- Published in:
- Cardiovascular Research, 2000, v. 47, n. 1, p. 166, doi. 10.1016/S0008-6363(00)00081-X
- By:
- Publication type:
- Article
Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 17, p. 2009, doi. 10.1001/jama.298.17.2009
- By:
- Publication type:
- Article
Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction.
- Published in:
- Cardiovascular Research, 1998, v. 39, n. 3, p. 563, doi. 10.1016/S0008-6363(98)00084-4
- By:
- Publication type:
- Article
Endothelin in chronic heart failure: current position and future prospects.
- Published in:
- Cardiovascular Research, 1996, v. 31, n. 5, p. 665, doi. 10.1016/S0008-6363(96)00055-7
- By:
- Publication type:
- Article
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1727, doi. 10.1002/ejhf.3294
- By:
- Publication type:
- Article
Cardiovascular‐kidney‐metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1762, doi. 10.1002/ejhf.3304
- By:
- Publication type:
- Article
Use of medical therapy and risk of clinical events according to frailty in heart failure patients – A real‐life cohort study.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1717, doi. 10.1002/ejhf.3249
- By:
- Publication type:
- Article
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose‐lowering therapy: A pre‐specified analysis of the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1539, doi. 10.1002/ejhf.3269
- By:
- Publication type:
- Article
Dapagliflozin and quality of life measured using the EuroQol 5‐dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1524, doi. 10.1002/ejhf.3263
- By:
- Publication type:
- Article
Measuring congestion with a non‐invasive monitoring device in heart failure and haemodialysis: CONGEST‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1383, doi. 10.1002/ejhf.3290
- By:
- Publication type:
- Article
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1324, doi. 10.1002/ejhf.3253
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 5, p. 1125, doi. 10.1002/ejhf.3223
- By:
- Publication type:
- Article
Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON‐HF study.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 871, doi. 10.1002/ejhf.3167
- By:
- Publication type:
- Article
Cost‐effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA‐HF and DELIVER data.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 3, p. 664, doi. 10.1002/ejhf.3197
- By:
- Publication type:
- Article
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 245, doi. 10.1002/ejhf.3114
- By:
- Publication type:
- Article
Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 107, doi. 10.1002/ejhf.3085
- By:
- Publication type:
- Article
Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS‐986231).
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 142, doi. 10.1002/ejhf.3077
- By:
- Publication type:
- Article
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2202, doi. 10.1002/ejhf.3044
- By:
- Publication type:
- Article
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE‐HF model.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 11, p. 1962, doi. 10.1002/ejhf.3028
- By:
- Publication type:
- Article
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 11, p. 2078, doi. 10.1002/ejhf.3000
- By:
- Publication type:
- Article
Knowledge about self‐efficacy and outcomes in patients with heart failure and reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 10, p. 1831, doi. 10.1002/ejhf.2944
- By:
- Publication type:
- Article
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1663, doi. 10.1002/ejhf.3001
- By:
- Publication type:
- Article
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1606, doi. 10.1002/ejhf.2962
- By:
- Publication type:
- Article
Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991–2016.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1213, doi. 10.1002/ejhf.2965
- By:
- Publication type:
- Article
Changes in mid‐regional pro‐adrenomedullin during treatment with sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1396, doi. 10.1002/ejhf.2957
- By:
- Publication type:
- Article
The cost‐effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: A European health‐economic analysis of the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1386, doi. 10.1002/ejhf.2940
- By:
- Publication type:
- Article